Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly ( LLY 14.56%). But now, an investment ...

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

The AD market is expected to be worth tens of billions ... I think now is still a good opportunity to invest in Eli Lilly, despite some of the near-term uncertainties. As a long-term investor ...

which promoted its compounded products in a Super Bowl ad this year, has said they plan to continue selling semaglutide to fill individual prescriptions. Eli Lilly, which made more than $5 ...

The advertising watchdog National Advertising Division said Wednesday that Apple advertising claimed Apple Intelligence ...

When combined with funding from previously reported warrant exercises and ad Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

This context informed Eli Lilly’s first direct-to-consumer (DTC) ad campaign for Ebglyss, its first-line biologic treatment for moderate-to-severe atopic dermatitis. The drug, which was approved by ...

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response.